Other studies, including the cardiovascular outcomes trial (TRIUMPH-Outcomes, NCT06383390), remain active, and new trials may be recruiting
Well show you how to maximize your world, from our Protein Powders to our Weight Gainers
In this article GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy), liraglutide (Saxenda, Victoza), and tirzepatide (Mounjaro, Zepbound) are making headlinesand for good reason
Contraindications include concurrent use with other tirzepatide-containing formulations or GLP-1 receptor agonist medications
Maintaining normal conditions at the injection site keeps absorption predictable
2025 FDA shipping data shows that shipments of semaglutide and tirzepatide dropped by 90 and 34 percent, respectively, from June 2024 to June 2025